Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events

Residual inflammatory risk (RIR) after acute coronary syndromes (ACS) may identify patients likely to benefit from anti-inflammatory therapies.

Source: Atherosclerosis - January 18, 2021 Category: Cardiology Authors: Roland Klingenberg, Soheila Aghlmandi, Baris Gencer, David Nanchen, Lorenz R äber, David Carballo, Sebastian Carballo, Barbara E. Stähli, Ulf Landmesser, Nicolas Rodondi, François Mach, Stephan Windecker, Heiner C. Bucher, Arnold von Eckardstein, Thoma Source Type: research